Dr Alexander Romanov (State Research Institute of Circulation Pathology) discusses the RAS trial that investigates radiofrequency (RF) ablation versus medical therapy for symptomatic frequent ventricular premature complexes as a first-line therapy in paediatric populations.
Filmed on site at EHRA 2019 by Radcliffe Cardiology
1. What is aim of this study?
2. How was the ablation procedure conducted?
3. What were your results?
4. What are the key implications for practice?
Videographer: Tom Green/Mike Knight/Tom Brown
Interviewer: Mirjam Boros